Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001140361-18-019792
Filing Date
2018-04-26
Accepted
2018-04-26 16:49:16
Documents
3
Group Members
BAUPOST GROUP GP, L.L.C.SETH A. KLARMAN

Document Format Files

Seq Description Document Type Size
1 NONE doc1.htm SC 13D/A 186013
2 JOINT FILING AGREEMENT ex_a.htm EX-1.A 5692
3 MASTER ASSIGNMENT AND ACCEPTANCE AGREEMENT ex_e.htm EX-1.E 160099
  Complete submission text file 0001140361-18-019792.txt   353372
Mailing Address 10 ST JAMES AVE SUITE 1700 BOSTON MA 02116
Business Address 10 ST JAMES AVE SUITE 1700 BOSTON MA 02116 617-210-8300
BAUPOST GROUP LLC/MA (Filed by) CIK: 0001061768 (see all company filings)

EIN.: 043402144 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Subject) CIK: 0001382911 (see all company filings)

EIN.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-83422 | Film No.: 18779316
SIC: 2834 Pharmaceutical Preparations